A new study has found that Merck & Co., the maker of the human papillomavirus (HPV) vaccine Gardasil, neglected to examine the drug’s effect on the reproductive systems of women.
As a result of that neglect, as well as the inherent dangers behind the vaccine, an Australian girl has suffered debilitating consequences, with her ovaries completely destroyed, the website Elite Insight reported. The British Medical Journal, which publicized the case of the 16-year-old girl, said the damage occurred three years after she was vaccinated.
The BMJ summarized:
“Its occurrence raises important questions about causation, which may signal other systemic concerns. This patient presented with amenorrhoea after identifying a change from her regular cycle to irregular and scant periods following vaccinations against human papillomavirus. She declined the oral contraceptives initially prescribed for amenorrhoea. The diagnostic tasks were to determine the reason for her secondary amenorrhoea and then to investigate for possible causes of the premature ovarian failure identified. Although the cause is unknown in 90% of cases, the remaining chief identifiable causes of this condition were excluded. Premature ovarian failure was then notified as a possible adverse event following this vaccination. The young woman was counselled regarding preservation of bone density, reproductive implications and relevant follow-up. This event could hold potential implications for population health and prompts further inquiry.”
‘Denied a fundamental right’
In the report, entitled, “Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination,” Little wrote that Merck had only tested Gardasil’s effects on the testes of rats.
In contacting the Therapeutic Goods Administration (TGA) of Australia – which is the equivalent of the United States’ FDA – for information about the safety testing of Gardasil on ovaries, Little found that the TGA only had records of the tests on rat testes, but none on the effects of the drug on rat ovaries.
Read more at: